Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117410) titled 'Observational Study of Objective Response Rate to Ivonescimab Combined with Chemotherapy in Patients with Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma' on Jan. 23.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Zhujiang Hospital of Southern Medical University
Condition:
locally advanced resectable oral squamous cell carcinoma and oropharyngeal squamous cell carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-01
Target Sample Size: Observation group:20;
Countries of Recruitment:
China
To know more, visit h...